Myrbetriq™ (Mirabegron) to Improve Disordered Sleep in Subjects With Lower Urinary Tract Symptoms (LUTS)
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The objective of this exploratory pilot study is to assess whether Mirabegron (Myrbetriq™)
will improve the quality of sleep and Lower Urinary Tract Symptoms (LUTS) in men and women
presenting with LUTS and disordered sleep.
Details
Lead Sponsor:
Southern Illinois University
Collaborators:
Astellas Scientific & Medical Affairs, Inc. Sisters of the Third Order of St. Francis